Loading...

Run DIPG is excited to announce that Dr Matt Dun, as part of solution-based research at Hunter Medical Research Institute (HMRI)has been awarded an Investigator Grant, receiving $627,250 in the latest round of National Health and Medical Research Council (NHMRC) funding.

Dr Dun and his team are collaborating with all major children’s hospitals in NSW, and international hospitals in Switzerland and California, dedicated to developing innovative, patient-focused approaches to treat high-risk paediatric cancers.

Dr Dun and his team are employing sophisticated technologies to investigate the preclinical efficacy of treatments targeting the cellular machinery they have identified that drives the rapid growth and treatment-resistant nature of cancers such as diffuse intrinsic pontine glioma (DIPG) and relapsed acute myeloid leukaemia, recognised as the most aggressive of all childhood cancers.

The University of Newcastle’s Acting Deputy Vice-Chancellor for Research and Innovation, Professor Deborah Hodgson, said the impressive outcome was a testament to the world-class research being carried out at the University of Newcastle.

“I’d like to congratulate all of the recipients on a fantastic outcome. We look forward to seeing how the research carried out here in Newcastle can be applied to help solve some of the world’s most critical health problems.”

The grant recognises Dr Dun as a leader in his field and allows him to continue his crucial research for at least another five years.

2019-09-06T08:45:03+10:00